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COMMENTARY
Correction for ‘‘Icy insights from emperor penguins,’’ by Colleen
Cassady St. Clair and Mark S. Boyce, which appeared in issue 6,
February 10, 2009, of Proc Natl Acad Sci USA (106:1691–1692;
first published February 4, 2009; 10.1073/pnas.0812940106).
The authors note that due to a printer’s error in the Fig. 1
legend, the two panels were credited incorrectly. The corrected
legend and its figure appear below.
www.pnas.orgcgidoi10.1073pnas.0901386106
Fig. 1. Life cycle for emperor penguins at Terre
Adélie, Antarctica. Survival probability is Si for stage
i. Minimum age at first breeding was 3 years; once
recruited, birds reproduce annually with probability
Sa Pb, where Pb is the proportion of breeders. BS is
overall breeding success. Translation of this life cycle
into a population projection matrix was described by
Jenouvrieretal. (13). In thecurrentarticle, Jenouvrier
et al. (2) link past demographic responses to warm
years to IPCC models of projected climate change to
predict a persistent decline in the emperor penguin
population at Terre Adélie and a 36% likelihood of
extinction by 2100. [Photo of emperor penguins by
Gordon Court. Population model reproduced with
permission from Jenouvrier et al. (13) (Copyright
2005, Ecological Society of America).]
CELL BIOLOGY
Correction for ‘‘Reprogramming of murine and human somatic
cells using a single polycistronic vector,’’ by Bryce W. Carey,
Styliani Markoulaki, Jacob Hanna, Kris Saha, Qing Gao,
Maisam Mitalipova, and Rudolf Jaenisch, which appeared in
issue 1, January 6, 2009, of Proc Natl Acad Sci USA (106:157–162;
first published December 24, 2008; 10.1073pnas.0811426106).
The authors note that on page 157, in the right column, the
heading, ‘‘Generation of Mouse Ips Cells Using a Single Poly-
cistronic Virus,’’ should instead read: ‘‘Generation of Mouse iPS
Cells Using a Single Polycistronic Virus.’’ On page 158, right
column, in line 5 of the first paragraph and line 6 of the second
paragraph, ?8 should instead appear as 8. On page 159, left
column, line 9 of the second paragraph, the sentence ‘‘This is two
orders of magnitude lower than that of ‘secondary’ fibroblasts or
B cells carrying preselected DOX-inducible proviruses (19),’’
should read: ‘‘This is one to two orders of magnitude lower than that
of ‘primary’ infected fibroblasts (3, 7).’’ Also on page 159, in the
right column, the heading, ‘‘Generation of Human Ips Cells Using
a Single Polycistronic Virus,’’ should instead read: ‘‘Generation of
Human iPS Cells Using a Single Polycistronic Virus.’’ Finally, on
page 160, in the first paragraph of Materials and Methods, the
sequence for the P2A peptide “GCCACGAAGCAAGCAG-
GAGATGTTGAAGAAAACCCCGG GCCT” should instead
read “GCCACGAACTTCTCTCTGTTAAAGCAAGCAGG-
AGATGTTGAAGAAAACCCCGGGCCT.”
www.pnas.orgcgidoi10.1073pnas.0900269106
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chiglia, Alexander V. Zhdanov, Murtaza M. Tambawala, Eoin P.
Cummins, Mona Monfared, Terence A. Agbor, John F. Garvey,
Dmitri B. Papkovsky, Cormac T. Taylor, and Bernard B. Allan,
which appeared in issue 7, February 17, 2009, of Proc Natl Acad
Sci USA (106:2188–2193; first published January 28, 2009;
10.1073pnas.0808801106).
The authors note that the author name Murtaza M. Tam-
bawala should have appeared as Murtaza M. Tambuwala. The
online version has been corrected. The corrected author line
appears below.
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Mitochondrial biogenesis occurs in response to increased cellular
ATP demand. The mitochondrial electron transport chain requires
molecular oxygen to produce ATP. Thus, increased ATP generation
after mitochondrial biogenesis results in increased oxygen demand
that must be matched by a corresponding increase in oxygen
supply. We found that overexpression of peroxisome proliferator-
activated receptor- coactivator 1 (PGC-1), which increases mi-
tochondrial biogenesis in primary skeletal muscle cells, leads to
increased expression of a cohort of genes known to be regulated
by the dimeric hypoxia-inducible factor (HIF), a master regulator of
the adaptive response to hypoxia. PGC-1-dependent induction of
HIF target genes under physiologic oxygen concentrations is not
through transcriptional coactivation of HIF or up-regulation of
HIF-1 mRNA but through HIF-1 protein stabilization. It occurs
because of intracellular hypoxia as a result of increased oxygen
consumption after mitochondrial biogenesis. Thus, we propose
that at physiologic oxygen concentrations, PGC-1 is coupled to
HIF signaling through the regulation of intracellular oxygen avail-
ability, allowing cells and tissues to match increased oxygen demand
after mitochondrial biogenesis with increased oxygen supply.
hypoxia  metabolism  mitochondria  transcription
In a range of physiologic states where increased tissue workloadelevates ATP demand, cells respond by increasing mitochondrial
mass. Mitochondrial biogenesis occurs in response to a number of
environmental cues where energy requirements are increased,
including skeletal muscle exercise (1), brown fat cold exposure
(during adaptive thermogenesis) (2), and in the developing myo-
cardium (3, 4). Mitochondria consume pyruvate to generate ATP,
through the activity of the citric acid cycle and electron transport
chain, the terminal enzyme of which (cytochrome oxidase), re-
quires molecular oxygen. Under physiologic conditions, tissue
oxygen levels are generally limiting. Therefore, increased mitochon-
drial activity results in elevated ATP only when accompanied by a
corresponding increase in oxygen supply.
Peroxisome proliferator-activated receptor- (PPAR) coactiva-
tor 1 (PGC-1) regulates mitochondrial biogenesis (5) in multiple
cell types (6–9) through coactivation of key transcription factors
including nuclear respiratory factors (NRF-1 and NRF-2) (5, 10),
estrogen-related receptor- (ERR) (11, 12), Gabpa/b (5, 7),
PPARs (13), and the thyroid hormone receptor (14). These tran-
scription factors support mitochondrial biogenesis through the
expression of genes encoding proteins involved in oxidative phos-
phorylation, fatty acid oxidation, heme biosynthesis, and mitochon-
drial protein import (15). The coordinated transcription of genes
enhanced by PGC-1 supports a net increase in oxidative phos-
phorylation with an accompanying increase in oxygen demand.
PGC-1  is enriched in skeletal muscle (7) and is induced in
response to exercise (16–18). Although recent studies have iden-
tified an important physiological role of PGC-1 in skeletal muscle
responses to exercise (19, 20) the underlying mechanisms remain
unclear. To investigate these mechanisms, we performed gene
expression profiling of primary human skeletal muscle cells over-
expressing PGC-1. We found that PGC-1 overexpression leads
to increased expression of a cohort of genes previously shown to be
strongly induced in hypoxia in a manner dependent on hypoxia
inducible factor (HIF-1), a master regulator of hypoxia-dependent
gene expression that consists of a HIF-1/ARNT dimer (21, 22).
In hypoxia, HIF-1 initiates a program of gene expression that
facilitates increased oxygen supply to overcome the initial hypoxic
insult. HIF-1 binds to the core hypoxia response element (HRE)
motif in target genes (22, 23). HIF-1, the oxygen-sensitive subunit
is constitutively expressed; however, it is continuously targeted for
ubiquitination and degradation in a manner dependent on the
hydroxylation of 2 proline residues within the oxygen-dependent
degradation domain (ODDD) (24–26). The HIF hydroxylases
responsible for this reaction require molecular oxygen and ferrous
iron (Fe2) and 2-oxoglutarate for activity. Upon hydroxylation,
HIF-1 is targeted by the Von Hipple-Lindau (VHL) protein to
ubiquitination and degradation (24, 27, 28). Hydroxylase inhibition
in hypoxia leads to a rapid stabilization of HIF-1 with a subsequent
increase in HIF-1 target gene expression.
In the current study, we show that PGC-1-induced mitochon-
drial biogenesis results in increased oxygen consumption, leading to
a decrease in intracellular oxygen availability to HIF-hydroxylases,
resulting in stabilization of HIF-1. We hypothesize that this HIF
activation facilitates the elevated generation of ATP after mito-
chondrial biogenesis by matching the increased oxygen demand
with an increase in oxygen supply.
Results
PGC-1 Activates HIF-1 Target Genes in Primary Human Skeletal
Muscle Myotubes. We used gene expression profiling to determine
global transcriptional responses in primary differentiated human
skeletal muscle myotubes infected with either an adenovirus ex-
pressing PGC-1 (Ad-PGC-1) or a control adenovirus expressing
GFP (Ad-GFP). PGC-1 overexpression resulted in elevated
PGC-1 mRNA (99.6  36.1-fold; n  3, P  0.01) and increased
expression of a cohort of known PGC-1 target genes including
Author contributions: K.A.O., D.B.P., C.T.T., and B.B.A. designed research; K.A.O., S.C.,
A.V.Z., M.M.T., E.P.C., M.M., T.A.A., and J.F.G. performed research; A.V.Z. and D.B.P.
contributed new reagents/analytic tools; K.A.O., A.V.Z., D.B.P., C.T.T., and B.B.A. analyzed
data; and K.A.O., C.T.T. and B.B.A. wrote the paper.
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
Freely available online through the PNAS open access option.
1C.T.T. and B.B.A. contributed equally to this work.
2To whom correspondence should be addressed. E-mail: cormac.taylor@ucd.ie.
This article contains supporting information online at www.pnas.org/cgi/content/full/
0808801106/DCSupplemental.
© 2009 by The National Academy of Sciences of the USA
2188–2193  PNAS  February 17, 2009  vol. 106  no. 7 www.pnas.orgcgidoi10.1073pnas.0808801106
genes involved in mitochondrial function (Table S1). We also
identified a cohort of up-regulated genes previously shown to
be regulated by HIF in response to cellular hypoxia. These
included genes involved in glycolysis, angiogenesis, and iron
transport (Table S2). Real-time PCR was performed to con-
firm the up-regulation of a selected group of these HIF-1
target genes including the transferrin receptor (TfR; Fig. 1A).
The TfR provides the main route for iron uptake, which is a
critical cofactor for a number of mitochondrial enzymes. For
this reason, we selected the TfR for further investigations into
the mechanisms by which PGC-1 regulates gene expression.
We confirmed PGC-1-dependent induction of TfR mRNA
levels by real-time PCR in 2 skeletal muscle cell lines. First,
differentiated C2C12 mouse skeletal muscle myotubes dem-
onstrated a 4.5-fold increase in TfR mRNA when infected with
Ad-PGC-1 (Fig. 1B). Next, we used rat skeletal muscle cells
(L6) to generate a cell line stably overexpressing PGC-1
(leading to a 10-fold increase in PGC-1 mRNA) and found
that these cells expressed TfR protein at higher levels than
control cells (Fig. 1C). Furthermore, both VEGF-A and TfR
mRNA were expressed at higher levels in PGC-1-L6 cells
than in control cells and this up-regulation was enhanced in
cells cultured at 1% oxygen (Fig. 1D).
PGC-1 Activates the TfR in a HIF-Dependent Manner. To examine
whether PGC-1 induction of TfR mRNA is caused by activation
of TfR transcription, we cotransfected a 1.7-kb TfR promoter
luciferase reporter construct (pTfRA-luc) with a PGC-1 expres-
sion vector (or an empty vector) into C2C12 cells. Cotransfection
of pTfRA-luc with PGC-1 resulted in a 2.7-fold increase in
reporter activity relative to control (Fig. 2A). To identify the DNA
elements that PGC-1 is acting through on the TfR promoter a
series of promoter truncations were generated. PGC-1-dependent
activation of the TfR occurred with all of the deletion constructs,
including the shortest construct containing the minimal active
transcriptional region (refs. 29 and 30; Fig. 2A). Sequence analysis
of the TfR promoter region revealed a consensus HRE that has
been identified as a functional HIF binding site at position 90 to
83 relative to the transcription start site (31, 32). Having identified
this HRE, we next tested whether PGC-1 overexpression increases
HRE-luciferase reporter activity. PGC-1 overexpression in
C2C12 cells resulted in increased HRE activity compared with
controls (Fig. 2A Lower).
To investigate the importance of this HRE in PGC-1-
induced TfR activation, a TfR promoter construct containing a
TACGT to AATTC mutation in the HIF binding site was
generated. Mutation at this site has been shown to inactivate this
HRE (32). C2C12 cells were cotransfected with either a wild-
type (pTfRB-luc) or mutant (pTfRBmut-luc) reporter construct
and a PGC-1 expression vector or empty vector. At 21% O2,
cells overexpressing PGC-1 demonstrated a significantly in-
creased activity of the wild-type pTfRB-luc. Hypoxia resulted in
a 1.5-fold increase in basal pTfRB-luc reporter activity. Simi-
larly, the hydroxylase inhibitor dimethyloxallyl glycine (1 mM)
increased TfR expression by 95  41.2% (n  3). Furthermore,
C2C12 cells overexpressing PGC-1 responded to hypoxia with
a 9.7-fold increase in wild-type pTfRB-luc reporter activity.
Mutation of the HRE greatly attenuated enhanced luciferase
expression by PGC-1 at 21% and 1% O2 (Fig. 2B). These data
show that PGC-1 overexpression increases activation of the
TfR promoter at 1% O2 in a manner at lease in part dependent
on the presence of an intact HRE at positions 90 to 83.
We next investigated the role of HIF-1, the transcription factor
that binds to this site, by using siRNA that effectively depletes
HIF-1 when compared with scrambled control siRNA (74%
decrease in protein expression). In HeLa cells, at 1% O2 HIF is
maximally stabilized and PGC-1 overexpression does not enhance
this stabilization, furthermore HIF-1 siRNA abolishes HIF-1
expression in all cases (Fig. 2C). HeLa cells were transfected with
the pTfRB-luc reporter construct and either a pcDNA-PGC-1
expression vector or an empty pcDNA control vector. Luciferase
expression was measured after 24-h exposure to 21% or 1% O2.
Unlike C2C12 cells, PGC-1 expression in HeLa cells did not
activate luciferase expression at 21% O2 (likely because of different
levels of basal oxygen consumption); however, hypoxia induced
pTfRB-luc by 2-fold in HeLa cells transfected with control
siRNA. Overexpression of PGC-1 potentiated this response.
Silencing of HIF-1 abolished both hypoxia-induced pTfRB-luc
activity and PGC-1-dependent potentiation of this response (Fig.
2D). These data indicate that PGC-1 overexpression enhances
TfR promoter activity at 1% O2 via HIF-1-dependent mecha-
nisms.
Using both DNA-binding assays and ChIP, we found no evidence
that PGC-1 becomes physically associated with the HRE of the
TfR promoter. We also discounted the possibility that overexpres-
sion of PGC-1 activates HIF-1 mRNA expression by using gene
array and real-time PCR. Therefore, PGC-1 regulates HIF-1-
dependent gene expression in a manner that is caused by PGC-1
acting as a direct coactivator of HIF-1 or by increasing HIF-1
mRNA expression.
PGC-1 Overexpression Decreases Intracellular O2 Levels. The
HIF-1 protein is extremely oxygen labile because of prolyl hy-
droxylase (PHD)/VHL activity and proteosome-dependent degra-
dation as outlined in the Introduction. Therefore, a possible mech-
anism by which PGC-1 could activate HIF-1 is via regulation of
intracellular oxygen availability through increased mitochondrial
A
B C
D
Fig. 1. Identification of HIF target gene expression in PGC-1-overexpressing
cells. (A) RT-PCR of HIF target genes in primary human skeletal muscle cells
infected with either Ad-GFP or Ad-PGC-1. (B) RT-PCR of TfR mRNA in C2C12
myotubes infected with either Ad-GFP or Ad-PGC1. (C) TfR protein expres-
sion in L6 myotubes stably expressing PGC-1 (L6-PGC-1) compared with
control L6-laczeo (LZ) cells. -Actin was used as a loading control. (D) RT-PCR
analysis of VEGF-A and TfR in L6-PGC-1 and L6-laczeo myotubes maintained
at 21% or 1% atmospheric oxygen for 24 h. *, P  0.05; **, P  0.01; mean 
SEM; n  3 throughout.
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biogenesis. It has been shown that inhibition of mitochondrial
respiration by nitric oxide and other inhibitors of the respiratory
chain results in redistribution of oxygen to nonmitochondrial tar-
gets such as PHD enzymes, resulting in destabilization of HIF-1
in hypoxia (33). Conversely, we hypothesized that an increase in
mitochondrial respiration subsequent to PGC-1-induced mito-
chondrial biogenesis may lead to a decrease in intracellular oxygen
availability and the stabilization and accumulation of HIF-1. To
investigate whether PGC-1 expression results in decreased cellular
O2 availability, we measured extracellular O2 concentration in L6
cells stably expressing PGC-1 by using fluorescence quenching
oxymetry. To mimic tissue oxygen levels, this experiment was
carried out at 10% atmospheric oxygen. L6-PGC-1 myotubes
demonstrated a marked reduction in extracellular pO2 levels com-
pared with control cells (Fig. 3A Upper), suggesting that these cells
are consuming oxygen at a significantly greater rate than control
cells. Increased mitochondrial mass in L6-PGC-1 cells was con-
firmed by immunoblot analysis of cellular levels of cytochrome c
(Fig. 3A Lower).
We next confirmed increased mitochondrial mass in C2C12 cells
overexpressing PGC-1 by independent quantitative fluorescence
imaging of the mitochondrial markers tetramethylrhodamine
methyl ester (TMRM) and mitotracker green (MTG). In each case
cells overexpressing PGC-1 demonstrated increases in fluores-
cence, thus confirming mitochondrial biogenesis in PGC-1-
overexpressing cells (Fig. 3B). In separate experiments, C2C12 cells
were cotransfected with an intracellular oxygen probe (34) and
either a PGC-1 expression vector or an empty vector and intra-
cellular oxygen levels were measured under oil (to prevent oxygen
diffusion). Cells overexpressing PGC-1 had decreased intracellu-
lar oxygen levels, reflecting increased oxygen consumption com-
pared with control cells (Fig. 3C). Similar results were obtained for
the rat pheochromocytoma cell line PC-12 for which this protocol
was originally developed (Fig. S1). In summary, these data suggest
that PGC-1 overexpression leads to mitochondrial biogenesis and
subsequently decreased intracellular oxygen levels in skeletal mus-
cle cells.
PGC-1 Overexpression Results in HIF-1 Stabilization and Decreased
PHD Activity. The data presented thus far led us to hypothesize that
PGC-1-dependent increases in mitochondrial oxygen consump-
tion results in a decrease in intracellular oxygen availability for
nonrespiratory dioxygenases such as HIF hydroxylases. To test this
hypothesis, HeLa cells expressing PGC-1 were exposed to either
21%, 10%, or 5% atmospheric O2 for 30 min. Immunoblot analysis
revealed no increase in HIF-1 levels in HeLa cells overexpressing
PGC-1 at 21% O2 where oxygen availability is not likely to be a
limiting factor. However, at 10% and 5% atmospheric O2 (which
represent intermediate levels of tissue oxygen where HIF is not
maximally activated; see Fig. S2), PGC-1 overexpression resulted
in increased HIF-1 levels when compared with control cells (Fig.
4A). Importantly, inhibition of mitochondrial respiration with an-
timycin A reversed this effect (Fig. 4B). These data suggest that
when oxygen is limited PGC-1-induced increases in oxygen con-
sumption results in HIF-1 stabilization.
To investigate whether the increased HIF-1 in PGC-1-
overexpressing cells is a result of inhibition of the oxygen-dependent
HIF hydroxylases, we used a construct containing amino acid
residues 521–652 of HIF-1, which comprises the ODD of HIF-1,
fused to a V5-tagged GFP (ODD-GFP-V5). The ODD of HIF-1
confers hydroxylase-dependent oxygen sensitivity to the V5-tagged
GFP protein (33). HeLa cells were transfected with an ODD-
GFP-V5 expression vector and either a PGC-1 expression vector
or an empty vector. Cells were then exposed to either 21% or 10%
A
B
C
D
Fig. 2. Role of HIF-1 in the transactivation of the TfR promoter in cells overexpressing PGC-1. (A) (Upper) A TfR promoter-luciferase truncation reporter series
was cotransfected with PGC-1 expression vector or control vector. Luciferase activity was measured. (Lower) HRE-luciferase activity was measured in C2C12
cotransfected with PGC-1 expression vector. (B) Wild-type (pTfRB-luc; Left) or HRE-mutant TfR reporter (pTfRBmut-luc; Right) constructs were cotransfected
in C2C12 myoblasts with a PGC-1 expression vector or control vector. Luciferase expression was measured after 24-h exposure to 21% or 1% O2. (C) Immunoblot
analysis demonstrates siRNA silencing of HIF1- in HeLa cells exposed to hypoxia and cotransfected with PGC-1 expression vector or a control vector. (D) HIF-1
siRNA was used to reduce HIF-1 expression in HeLa cells. Cells were cotransfected with TfR luciferase reporter and PGC-1 expression vector or control vector.
Luciferase expression was measured after exposure to 21% or 1% O2 for 24 h. *, P  0.05; **, P  0.01; mean  SEM; n  3 throughout.
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atmospheric O2 for 30 min. Immunoblot analysis of ODD-GFP-V5
expression demonstrated that, like endogenous HIF-1 levels,
ODD-GFP-V5 expression is increased with PGC-1 at 10% oxy-
gen, indicating that PGC-1-induced mitochondrial biogenesis
results in the inhibition of HIF hydroxylases when oxygen is limited
(Fig. 4C). We carried out similar experiments in C2C12 cells and
found the same results (Fig. 4D). Interestingly, PGC-1 expression
in C2C12 cells was sufficient to stabilize ODD-GFP-V5 protein
levels at 21% O2. However, a further increase in ODD-GFP-V5
protein was seen in cells overexpressing PGC-1 exposed to 10%
O2 for 30 min. Importantly, PGC-1 overexpression did not sig-
nificantly alter PHD mRNA expression levels in primary human
skeletal muscle cells (PHD1 fold change  0.94  0.22, P  0.18;
PHD2 fold change  1.00  0.08, P  0.48; PHD3 fold change 
1.01  0.17, P  0.47) or protein levels in HeLa or C2C12 cells (Fig.
S3). Furthermore, hypoxia did not alter PGC-1 expression levels,
indicating that these potentially alternative mechanisms are not
mediating the effects of PGC-1 overexpression on HIF or the
ODD-GFP construct (Fig. S3). These data suggest that PGC-1
overexpression results in HIF-1 stabilization, which is caused by
inhibition of hydroxylation of the ODD of HIF-1. Taken together,
the results of this study indicate that PGC-1-induced increases in
oxygen consumption at physiologic oxygen levels results in de-
creased intracellular oxygen availability with the subsequent stabi-
lization/transactivation of HIF-1 and resultant expression of HIF-
1-dependent target genes (Fig. 5).
Discussion
In a number of physiologic conditions, increased cellular ATP
demand is facilitated by mitochondrial biogenesis. A central regu-
lator of the expression of mitochondrial genes during biogenesis is
PGC-1 (5). Because mitochondria require oxygen to produce
ATP, an increase in oxygen consumption occurs to support in-
creased oxidative metabolism after mitochondrial biogenesis. In the
current study, we demonstrate that PGC-1 expression in primary
human skeletal muscle cells activates the expression of HIF-1 target
genes and provide evidence that it is the increased consumption of
oxygen caused by PGC-1-dependent mitochondrial biogenesis
that leads to HIF-1 stabilization in skeletal muscle cells. A
consequence of HIF-1 stabilization in vivo is elevated tissue
oxygen supply that would facilitate the increased level of oxidative
C
BA
Fig. 3. Effects of PGC-1 overexpression on intracellular oxygen levels. (A)
(Upper) O2 concentration in L6-PGC-1 myotubes was measured by fluores-
cence quenching oxymetry. (Lower). Increased mitochondrial mass in L6-
PGC-1 myotubes was confirmed by immunoblot analysis of cellular levels of
cytochrome c. (B) C2C12 cells were transfected with either PGC-1 expression
vector or control vector, and mitochondrial mass and activity was imaged with
MTG (Upper) and TMRM (Lower), respectively. (Bar: 20 m.) (C) C2C12 cells
were cotransfected with near-infrared (NIR) oxygen probes, and either
PGC-1 expression vector or control vector and oxygen consumption was
determined. *, P  0.05; **, P  0.01; mean  SEM; n  3 throughout.
A
B
C
D
Fig. 4. Effect of PGC-1 overexpression on HIF-1 stabilization and PHD
activity. (A) Immunoblot analysis of HIF-1 in HeLa cells transfected with either
PGC-1 expression vector or control vector at either 21% and 10% atmo-
spheric O2 (Upper) or 21% and 5% atmospheric O2 (Lower). (B) HeLa cells were
exposed to 21% and 5% oxygen with or without PGC-1 overepression and
antimycin A (1 g/mL), and HIF-1 levels were determined by Western blot
analysis. (C) Immunoblot analysis of ODD-GFP-V5 expression in HeLa cells
transfected with either PGC-1 expression vector or control vector at either
21% or 10% atmospheric O2. (D) Immunoblot analysis of ODD-GFP-V5 expres-
sion in C2C12 cells transfected with either PGC-1 expression vector or control
vector in 21% or 10% O2. n  3 throughout.
PGC-1
á
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á
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á
Target Genes
PHD
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Fig. 5. Schematic representation of HIF target gene expression by PGC-1.
PGC-1 expression results in mitochondrial biogenesis and increased oxygen
consumption. The resultant drop in intracellular pO2 levels leads to decreased
HIF hydroxylase activity and HIF stabilization with resultant gene expression
that facilitates an increase in oxygen supply.
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phosphorylation occurring as a result of mitochondrial biogenesis.
We show that physiologically relevant increases in O2 consumption
can lead to HIF-1 stabilization and activity.
A number of studies have demonstrated that inhibition of
mitochondrial function in cells exposed to low oxygen levels (1–3%)
reverses hypoxia-induced HIF-1 activity (35–38), suggesting an
important role of mitochondria in oxygen sensing. Hagen et al. (33)
demonstrated that inhibition of mitochondrial respiration during
hypoxia results in a destabilization of HIF-1. Furthermore, that
study showed that mitochondrial inhibition in hypoxia results in a
redistribution of oxygen from the mitochondria to the oxygen-
dependent prolyl hydroxylases located elsewhere in the cell. Our
current data provide evidence that the converse is also true, i.e., that
activation of mitochondrial activity, through the physiological ac-
tivator PGC-1, results in stabilization of HIF-1. A critical issue
is that increasing mitochondrial activity will only impact nonmito-
chondrial oxygen-dependent enzymes when oxygen is limiting but
not unavailable. When a system is anoxic, differences in mitochon-
drial activity will not impact on oxygen availability because there is
no oxygen to redistribute to mitochondria. However, in the phys-
iologic range, where oxygen is limiting and the constraints on
nonmitochondrial oxygen availability are determined by mitochon-
drial respiration, an increase in respiratory activity will impact
cellular oxygen availability to nonmitochondrial dioxygenases.
Interestingly, a recent study (39) has demonstrated that PGC-1
can activate VEGF expression by binding and coactivating ERR
at conserved sites on the VEGF promoter in a manner independent
of HIF-1. Stabilization of HIF-1 in primary skeletal muscle cells
infected with a PGC-1 adenovirus was not detected in these
experiments. However, HIF-1 activity was examined at near
anoxic conditions (0.2% oxygen). For the reason stated above, one
would not expect to see a HIF-dependent role at these extremely
low oxygen concentrations. In addition to demonstrating this HIF-
independent role of PGC-1, we provide evidence for a HIF-
dependent role for PGC-1 in the regulation of genes involved in
increasing tissue oxygen supply at higher oxygen concentrations.
In vivo, the activation of HIF-1 would result in enhanced oxygen
delivery to sustain augmented mitochondrial activity in PGC-1-
expressing cells. HIF-1 plays a well-established role in the induction
of factors involved in angiogenesis and erythropoesis, resulting in
increased vessel formation, heme synthesis, and red blood cell
production. The net effect of these actions will result in optimal
blood flow and oxygen supply to tissues with limiting oxygen supply.
Here, we provide evidence that in skeletal muscle HIF-1 may be
coupled to mitochondrial biogenesis through activation of TfR and
increased cellular uptake of iron in response to increased oxygen
demand, while at the same time facilitating oxygen delivery through
VEGF expression that may be both PGC-1 dependent and
independent.
Increased oxidative phosphorylation occurring as a result of
mitochondrial biogenesis is not without its consequences for the
cell. Oxidative phosphorylation results in the generation of mito-
chondrial reactive oxygen species (ROS). One mechanism in which
this may be counteracted is by HIF regulation of mitochondrial
activity. HIF-1 activates the expression of COX4–2 subunit and a
protease involved in COX4–1 degradation in hypoxia, resulting in
increased efficiency in electron transfer to molecular oxygen,
minimizing ROS production (40). HIF also increases PDK1 ex-
pression, a negative regulator of the citric acid cycle, which in turn
will lead to a decrease in ROS production (41, 42). Thus, it is
possible that a second function of PGC-1-dependent HIF-1
activation is the control of mitochondrial ROS production after
mitochondrial biogenesis, complementing PGC-1 activation of
genes encoding ROS-detoxifying enzymes (43). Furthermore, a
recently described role for HIF as a possible negative regulator of
mitochondrial biogenesis (44) may represent a negative feedback
loop to prevent excessive mitochondrial accumulation.
PGC-1 plays an important role in the skeletal muscle response
to exercise. PGC-1 expression is robustly induced by exercise (16,
17), resulting in mitochondrial biogenesis, a switch from glycolytic
fibers to increased mitochondrial-rich oxidative fibers and in-
creased glycogen deposition (19, 20). This PGC-1-induced mito-
chondrial biogenesis prepares the muscle for the next bout of
exercise, with an increased oxidative phosphorylation capacity,
resulting in greater capacity for endurance training. HIF-1  protein
levels also increase markedly in skeletal muscle in response to a
single bout of exercise (45), and the effect of PGC-1 on HIF-1 that
we describe here may prolong the activity of HIF-1 allowing for a
sustained adaptive response to exercise. Finally, skeletal muscle-
specific HIF-1 knock out mice demonstrate that the increased
expression of HIF target genes normally observed in response to
exercise is HIF-1 dependent, suggesting a role for HIF in the
adaptation of skeletal muscle in response to exercise (46). We
propose that PGC-1 activation in skeletal muscle cells leads to
increased oxygen consumption secondary to increased mitochon-
drial mass (Fig. 5). The resultant drop in intracellular pO2 leads to
HIF activation that in turn increases iron delivery and tissue
perfusion by increasing the expression of the TfR and angiogenic
and vasoactive factors. Thus, increased perfusion will facilitate the
increased oxygen requirements of the mitochondrial biogenesis that
initiated the initial drop in oxygen concentration. In parallel,
increased HIF-1 target gene expression may protect cells under-
going mitochondrial biogenesis from oxidative damage by decreas-
ing mitochondrial respiration. In summary, this study along with
other recent developments place the interaction of PGC-1 and
HIF-1 as central in the skeletal muscle response to increases in
oxygen consumption during exercise.
Materials and Methods
Tissue Culture. HeLa cells were cultured in MEM. C2C12 myoblasts were cultured
in DMEM with 10% FBS. L6-PGC-1 myoblasts were grown in -MEM containing
hygromycin (12.5 g/mL). L6-LZcellsweregrownin -MEMzeocin (25 g/mL). For
myotube formation, C2C12 L6 myoblasts were cultured in DMEM or -MEM
containing 2% horse serum (Lonza) for 96 h. Primary human skeletal muscle
myoblasts were grown in skeletal muscle cell growth medium and differentiated
inskeletalmusclecelldifferentiationmedium(Promocell) for13days.Forhypoxia
studies, cell culture dishes were maintained in a humidified hypoxia workstation
(Coy Laboratories) at the indicated oxygen concentration with 5% CO2 and the
balance N2. Extracellular pO2 measurements were made by fluorescence quench-
ing oxymetry (oxylite-2000; Oxford Optronix).
Adenoviral Infections. Recombinant Ad-GFP alone or PGC-1 plus eGFP (Ad-
Pgc1) were gifts from B. Lavan (Metabolex, Hayward, CA). Cells were infected at
a multiplicity of infection sufficient to infect 95% of cells based on GFP fluo-
rescence. Primary human skeletal muscle and C2C12 cells were analyzed after 96
and 72 h, respectively.
Stable Transfection of L6 Cells. L6-Glut4myc cells (a generous gift from A. Klip,
University of Toronto, Toronto) were converted to stable Flp-In host cells (L6-
lacZeo) by transfection with pFRT/lacZeo2 (Invitrogen). L6-lacZeo cells were sub-
sequently cotransfected with pOG44 and pEF5/FRT/V5-Dest containing full-
length human PGC-1 with a stop codon to prevent V5 tagging of PGC-1,
at a 9:1 ratio. Stably-transfected L6-PGC-1 cells were selected for hygro-
mycin resistance.
RNA Isolation and RT-PCR. Total RNA was extracted by using RNeasy mini elute
columns (Qiagen). One microgram of total RNA was reverse-transcribed by using
random primers (Invitrogen) and SuperScript II (Invitrogen). RT-PCR was per-
formed on an Applied Biosystems 7900HT fast real-time PCR system using primers
(Table S3). Results were normalized to 18s expression.
Microarray Analysis. One microgram of total RNA was labeled according to the
Gene Chip Whole Transcript Assay as provided by manufacturer (Affymetrix) and
hybridized to Human Exon 1.0ST Arrays (Affymetrix) overnight before scanning
in an Affymetrix GCS3000 7G scanner.
Whole-Cell Protein Extract Preparation and Immunoblot Analysis. Whole-cell
extracts were prepared in whole-cell lysis buffer [150 mM NaCL/25 mM TrisHCl,
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pH 8.0./1 mM EDTA/1% Nonidet P-40 and 1 protease inhibitor mixture (Sigma)].
Protein content was quantified and normalized by using the Bradford method
(Bio-Rad) and separated by electrophoresis on SDS/PAGE gels. TfR mAb (Zymed),
HIF-1 mAb (BD Transduction Laboratories), V5 mAb (Invitrogen), monoclonal
N-terminal GFP antibody (Sigma), monoclonal cytochrome c antibody (BD Bio-
sciences,) and monoclonal -actin (Sigma) were used. For mitochondrial inhibi-
tion, HeLa cells were treated with 1 g/mL with Antimycin A for 60 min.
Luciferase Reporter Assays and Expression Constructs. The TfR promoter (pTfRA-
Luc) in a promoterless luciferase reporter plasmid, pGL2-basic, and a pGL2-basic
vector containing a 455-bp fragment of the TfR promotor (pTfRB-Luc) was kindly
provided by Gaetano Cairo (Istituto Patologia Generale, Milan). The pTfR-Luc
gene truncation series was generated by PCR amplification from the pTfRB-Luc
construct, The following 5	 primers were used: 5	-AACAGATTGGACCTAG-
CACTG-3	 (pTfRC-luc), 5	- TACGTGCCTCAGGAAGTG-3	 (pTfRD-luc). The same 3	
primer was used for both constructs: 5	-CTGATATCCCGACGCTCT. Site-directed
mutagenesis was performed by using the Quik Change Kit (Stratagene) comple-
mentary oligonucleotides 5	-CAGAGCACCTCGCGAGCGaattcGCCTCAGGA-
AGTGACGC 5	-GCGTCACTTCTTCCTGAGGCGaattcGCTCGCGAGGTGCTCTG.
PGC-1 was subcloned into pDONR207 by using the gateway BP clonase in vitro
recombination reaction (Invitrogen) after PCR amplification from a human skel-
etal muscle cDNA library, using forward primer 5	-GGGG-attB1-ATGGCGTGGGA-
CATGTGCAACCAG-3	 and reverse primer 5	-GGGG-attB2-TTACCTGCGCAAGCT-
TCTCTGAGC-3	 and shuttled into pcDNA3.1/Nv5-DEST expression vector by using
the gateway LR in vitro recombination reaction (Invitrogen). pcDNA3-ODD-
GFP-V5hasbeendescribed (33). ForRNAinterferenceexperiments, siRNAagainst
HIF-1 and a nonspecific control siRNA (Dharmacon) were added at a final
concentration of 50 pmol/mL. At 80% confluence, cells were transfected with
reporter plasmids (0.5 g), expression vectors (0.5 g), and control -galactosi-
dase vector (0.1 g) per well of a 24-well plate by using fugen-6 (Roche). Expres-
sion of reporter gene activity was normalized to -galactosidase levels by using a
-galactosidase enzyme assay system (Promega).
Oxygen Probe Analysis. At 50% confluence, C2C12 cells were transfected with
expression vectors (0.1 g per well of 96-well plate) with Lipofectamine 2000. On
day 1 of differentiation, cells were transfected with 1.2 M MitoXpress O2 probe
(Luxcell Biosciences)/6 M Endo-Porter (Gene Tools) as described (34). Cells were
washed and analyzed on a fluorescent plate reader in 100 L of RPMI medium
1640 without serum or phenol red. To minimize contribution of glycolysis to ATP
production, C2C12 cells were preincubated for 2 h in serum-free RPMI medium
1640 containing 10 mM galactose and 1 mM pyruvate. To prevent oxygen
diffusion, experimental wells were covered in mineral oil.
Live Cell Monitoring of Mitochondrial Membrane Potential. C2C12 cells were
transfected at 50% confluence on glass-bottom dishes. On day 2 of differentia-
tion, cells were loaded with either 50 nM MTG or 20 nM TMRM for 30 min at 37 °C
(in the dark) in serum-free DMEM. The cells were washed twice and monitored in
serum-free DMEM by using an Olympus FU1000 laser scanning confocal micro-
scope. MTG and TMRM were maintained during a whole experiment at 10 nM
and20nm,respectively.MTGandTMRMwereexcitedat488nMand543nmwith
an argon laser (5% maximum power) or a helium neon laser (1.5%), respectively,
and the emission was collected through a 500- to 550-nm filter (MTG) or 550- to
600-nmfilter (TMRM)withphotomultiplieradjustedto555mV.Fluorescenceand
differential interference contrast (DIC) images were collected through an oil-
immersion 60 objective in 2 (for PC12) or 5 (C2C12) planes. Images were
analyzed by using FV1000 Viewer software (Olympus) and Adobe Photoshop.
Statistical Analysis. All experiments were carried out with a minimum of n  3.
Intergroup comparisons were made by Student’s t test with P  0.05 considered
statistically significant.
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